Many factors lead to treatment-resistance in cancer therapy. Some factors physical-chemical in nature: examples are hypoxia or the presence of high thiol content, which increase radiation resistance by well-known chemical principles. Others have a biochemical and molecular- biological basis: examples are endogenous radio-resistance, cell-cycle blocks or modified repair. The interactions of these factors are poorly understood in vivo, and studies of basic mechanisms of treatment resistance must have a very broad base of investigation. Several studies have suggested that low dose-rate, protracted ration (LDRR) can provide significant therapeutic advantages over conventional fractioned therapy, which consists of multiple discrete dose administrations, each of which is at high dose-rate. In order to apply this information to the clinic, however, an understanding is required regarding the interaction of LDRR with the chemical and biological modifiers of radioresistance. It is becoming increasingly apparent that hypoxia plays a key role in determining radioresistance, not only in the countless rodent studies over several decades, but in the current management of human cancer therapy. This project will test for the interaction of hypoxia with the radiation response of cells to LDRR. Several key questions will be addressed; 1) is there a normal dependence of radiation resistance on oxygen partial pressure for low dose-rate radiotherapy? 2) does low oxygen partial pressure affect the cell-cycle redistribution caused by low dose-rate radiation? and 3) is the response after low dose-rate radiation in vivo mediated through changes in tissue hypoxia or thiol content? 4) are hypoxic tumor cells sensitized by IUdR? It is hoped that these investigations will allow a firm rationale for the use of LDRR in tumors containing hypoxic cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA079862-04
Application #
6584604
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
$294,139
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Williams, Jerry R; Zhang, Yonggang; Zhou, Haoming et al. (2011) Sequentially-induced responses define tumour cell radiosensitivity. Int J Radiat Biol 87:628-43
Williams, Jerry R; Zhang, Yonggang; Zhou, Haoming et al. (2010) Tumor response to radiotherapy is dependent on genotype-associated mechanisms in vitro and in vivo. Radiat Oncol 5:71
Williams, Jerry R; Zhang, Yonggang; Zhou, Haoming et al. (2008) A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status. Int J Radiat Biol 84:253-64
Williams, Jerry R; Zhang, Yonggang; Zhou, Haoming et al. (2008) Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation. Int J Radiat Oncol Biol Phys 72:909-17
Williams, Jerry R; Zhang, Yonggang; Zhou, Haoming et al. (2008) Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution. Int J Radiat Biol 84:151-64
Fang, Ning; Tan, Wee Jin; Leong, Kam W et al. (2005) pH responsive adhesion of phospholipid vesicle on poly(acrylic acid) cushion grafted to poly(ethylene terephthalate) surface. Colloids Surf B Biointerfaces 42:245-52
Tan, Wee Jin; Teo, Gilbert P; Liao, Kin et al. (2005) Adhesion contact dynamics of primary hepatocytes on poly(ethylene terephthalate) surface. Biomaterials 26:891-8
Acs, Geza; Chen, Mei; Xu, Xiaowei et al. (2004) Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells. Cancer Lett 214:243-51
Chan, Vincent; Liu, Kuo-Kang; Le Visage, Catherine et al. (2004) Bioadhesive characterization of poly(methylidene malonate 2.12) microparticle on model extracellular matrix. Biomaterials 25:4327-32
Pan, Yi; Oprysko, Patricia R; Asham, Andrew M et al. (2004) p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23:4975-83

Showing the most recent 10 out of 12 publications